AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
2min chapter
#68 – IDWeek 2022 Recap: Late Breaking Trials and Pipeline Antibacterials
Breakpoints
Septobiprols - What's Next?
The numbers on patients with elevated vancoma mysees, I thought were very intriguing. And I think currently that's probably a place we're all looking to septariline more than dapto in those kinds of patients already. So, all in all, very exciting data and kudos to the authors. Rachel, do you want to guide us through the next exciting late breaking trial? This next study is Inhale WP3.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode